SAP Announces Strategic Alliances to Drive Forward Genomic Research

SAP Announces Strategic Alliances to Drive Forward Genomic Research

SAP Forms Strategic Collaborations With Stanford School of Medicine and the Global Alliance for Genomics and Health

WALLDORF, Germany, May 28, 2014 /PRNewswire/ -- SAP AG (NYSE: SAP) today announced a strategic collaboration with Stanford School of Medicine to research the contribution of genetics, environmental exposures, behavior and other factors to disease susceptibility using the power of the SAP HANA(R) platform. The company also announced its participation in the Global Alliance for Genomics and Health, a council of industry leaders working toward accelerating worldwide efforts to responsibly share and analyze large amounts of genomic and clinical data.

"SAP HANA has the potential to drive breakthrough innovation in genomics research and the healthcare industry overall," said Barbara Stortz, senior vice president, SAP HANA Platform for Healthcare and SAP HANA Native Development, SAP AG. "It is a big step for SAP to closely collaborate with the Stanford School of Medicine and join the Global Alliance for Genomics and Health to ultimately enable a better understanding of genetic underpinnings of health and disease."

Genomic Research Collaboration With Stanford School of Medicine

SAP's collaboration with Stanford School of Medicine aims to achieve a better understanding of global human genome variation and its implications in disease, particularly cardiovascular disease. Led by Carlos D. Bustamante, professor and director of the Stanford Center for Computational, Human and Evolutionary Genomics; Euan A. Ashley, associate professor of Medicine and Genetics; and Atul J. Butte, associate professor of Pediatrics and Genetics, the collaboration aims to advance genomics research in the clinical environment, ultimately leading to improved healthcare and personalized medicine.

Researchers have already leveraged SAP HANA to corroborate the results of a study that discovered that the genetic risk of Type II Diabetes varies between populations. The study looked at 12 genetic variants previously associated with Type II Diabetes across 49 individuals. With SAP HANA, researchers in Dr. Butte's lab were able to simultaneously query all 125 genetic variants previously associated with Type II Diabetes across 629 individuals. Using traditional methods, this analysis on this amount of data would have taken an unreasonable amount of time.

Global Alliance for Genomics and Health

The Global Alliance for Genomics and Health is an international non-profit alliance formed to help accelerate the potential of genomic medicine to advance human health. SAP joins a diverse group consisting of leading research institutions, healthcare providers and information technology and life science companies worldwide. As a member, SAP plans to contribute important perspectives and expertise to help identify best practices and establish a common framework of standards and harmonized approaches to enable the responsible, voluntary and secure sharing of genomic and clinical data.

For more information, visit the SAP News Center. Follow SAP on Twitter at @sapnews and @SAPInMemory.

Next Major Event: SAPPHIRE NOW

With SAPPHIRE NOW, SAP offers customers, partners and prospects even more opportunities to engage in dialogue with peers, participants and thought leaders around the globe. Being held in Orlando, Florida, June 3-5, 2014, this enhanced, real-time event connects attendees on site with global participants through state-of-the-art broadcast studios and an online experience that incorporates the latest social media and community functionality. Whether on site or online, participants can gain insight as to how SAP is delivering on its product strategy and helping organizations around the world to run better. For more information, visit www.sapphirenow.com. Follow SAPPHIRE NOW on Twitter at @SAPPHIRENOW, and for news and coverage during the event, visit the SAP News Center at www.news-sap.com.

About SAP

As market leader in enterprise application software, SAP (NYSE: SAP) helps companies of all sizes and industries run better. From back office to boardroom, warehouse to storefront, desktop to mobile device -- SAP empowers people and organizations to work together more efficiently and use business insight more effectively to stay ahead of the competition. SAP applications and services enable more than 258,000 customers to operate profitably, adapt continuously, and grow sustainably. For more information, visit www.sap.com.

Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "forecast," "intend," "may," "plan," "project," "predict," "should" and "will" and similar expressions as they relate to SAP are intended to identify such forward-looking statements. SAP undertakes no obligation to publicly update or revise any forward-looking statements. All forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. The factors that could affect SAP's future financial results are discussed more fully in SAP's filings with the U.S. Securities and Exchange Commission ("SEC"), including SAP's most recent Annual Report on Form 20-F filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates.

(c) 2014 SAP AG. All rights reserved.

SAP and other SAP products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of SAP AG in Germany and other countries. Please see http://www.sap.com/corporate-en/legal/copyright/index.epx#trademark for additional trademark information and notices.

For customers interested in learning more about SAP products:

Global Customer Center: +49 180 534-34-24

United States Only: 1 (800) 872-1SAP (1-800-872-1727)

For more information, press only:

Dorothea Sieber, +1(650) 276-8661, [email protected], PDT

Cathrin Von Osten, +49 (6227) 7-63908, [email protected], CET

SAP News Center press room; [email protected]

Logo - http://photos.prnewswire.com/prnh/20110126/AQ34470LOGO

SOURCE SAP AG

/Web site: http://www.sap.com

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.